NSGC 2026 has ended. This guide stays up as the record of who was there. Next: NSGC 2027, Nov 7–11, 2027 in Tampa

Who’s Going to NSGC 2026

Nov 10–14, 2026 Baltimore, MD ~2.5k attendees Website

86 exhibitors and 18 sponsored symposia at the National Society of Genetic Counselors (NSGC) 45th Annual Conference, a ~2,500-person, mostly clinical meeting of genetic counselors in clinics, testing labs and industry. As of Nov 12, 2026.

Format
Topic
Showing 1–14 of 86 organizations
OrganizationNSGC 2026 Attendance
Ambry Genetics
Aliso Viejo, CA
Genetic testing laboratories
Clinical genetic testing laboratory, part of Tempus, offering hereditary cancer, rare disease and whole-genome testing with RNA analysis and automatic reanalysis.
Booth
Exhibiting at Booth 1169
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Thu Nov 12
12:15–1:30pm
Uncovering the Complete Picture: Transforming Rare Disease Care for Every Patient
Shows how Ambry's clinical genome sequencing, RNA testing and automatic report reanalysis aim to raise diagnostic yield in rare disease.
Rare disease
Hosts a sponsored reception for attendees, Thu Nov 12, 8–11pm
Natera
Austin, TX
Genetic testing laboratories
Cell-free DNA testing laboratory offering prenatal screening (NIPT), carrier screening, oncology and transplant tests, and rare disease genetic testing.
Booth
Exhibiting at Booth 1263
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Wed Nov 11
12:15–1:30pm
Shifting the NIPT Paradigm: The Impact of Clinically Validated Accuracy at Low Fetal Fraction
Presents validation data for Natera's updated Panorama prenatal screen at fetal fractions as low as 1%, and what it means for counseling.
Prenatal and reproductive
Symposium
Thu Nov 12
7:45–8:30am
Beyond the Report: Bridging the Gap Between Rare Disease Diagnosis and Clinical Trial Access
Describes Natera's Zenith service, which matches patients' rare disease results to open clinical trials and alerts their clinicians.
Rare disease
Pharma and biotech companies
Biopharmaceutical company with approved treatments for Rett syndrome and Parkinson's disease psychosis, developing further medicines for neurological and rare conditions.
Booth
Exhibiting at Booth 963
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Fri Nov 13
7:45–8:30am
Rett Syndrome Management Your Way: Two Formulations of the First and Only FDA-Approved Treatment
Covers Rett syndrome care with both forms of Acadia's FDA-approved Rett treatment, DAYBUE and DAYBUE STIX.
Neurology · Rare disease
Pharma and biotech companies
AstraZeneca's rare disease company, with medicines for conditions including hypophosphatasia, lysosomal acid lipase deficiency, neurofibromatosis type 1 and complement disorders.
Booth
Exhibiting at Booth 1155
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Fri Nov 13
12:15–1:30pm
Recognize What Might Be Missed: Changing the Patient Journey in HPP, LAL-D, NF1
Reviews the clinical clues to hypophosphatasia, lysosomal acid lipase deficiency and neurofibromatosis type 1, to help clinicians recognize them earlier.
Rare disease
Ascendis Pharma
Copenhagen, Denmark
Pharma and biotech companies
Biopharmaceutical company developing long-acting treatments for rare endocrine and skeletal conditions, including achondroplasia.
Booth
Exhibiting at Booth 1055
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Wed Nov 11
7:45–8:30am
Discover Yuviwel® (navepegritide)
Introduces Ascendis' Yuviwel (navepegritide), covering how it works, its clinical trial results and how it is dosed.
Rare disease
Baylor Genetics
Houston, TX
Genetic testing laboratories
Genetic testing laboratory, a joint venture with Baylor College of Medicine, offering genome, exome and panel testing from prenatal through adult care.
Booth
Exhibiting at Booth 1376
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Wed Nov 11
12:15–1:30pm
Reimagining Genomic Testing Across the Care Continuum (from Prenatal to Postnatal)
Argues for genome-first prenatal testing and extra technologies beyond genome sequencing after birth, to find diagnoses that standard tests miss.
Prenatal and reproductive · Rare disease
BillionToOne
Menlo Park, CA
Genetic testing laboratories
Prenatal and cancer testing laboratory offering cell-free DNA prenatal screening, including fetal risk for recessive conditions, and liquid biopsy tests for oncology.
Booth
Exhibiting at Booth 1469
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Wed Nov 11
7:45–8:30am
Innovation with Intention: Advancing Prenatal Genetics Together
Discusses what new prenatal screening technologies can and cannot do, and how testing companies and genetic counselors can work together.
Prenatal and reproductive
BioMarin
San Rafael, CA
Pharma and biotech companies
Biotech company with medicines for rare genetic conditions, including achondroplasia and other skeletal disorders, PKU and several lysosomal storage disorders.
Booth
Exhibiting at Booth 1150, 1243, 1342
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Thu Nov 12
7:45–8:30am
Hypochondroplasia: Advancing Diagnosis and Genetic Counseling in an Evolving Clinical Landscape
Follows patients with hypochondroplasia from first suspicion to genetic confirmation and counseling, including FGFR3 variant interpretation and emerging treatments.
Rare disease
BridgeBio
Palo Alto, CA
Pharma and biotech companies
Biotech company developing medicines for genetic conditions, including transthyretin amyloid cardiomyopathy and achondroplasia.
Booth
Exhibiting at Booth 1247, 1347
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Fri Nov 13
7:45–8:30am
One Diagnosis, Many Conversations: The Evolving Landscape of Care in Achondroplasia and the Role of Genetic Counselors
Traces achondroplasia care from prenatal recognition through childhood treatment choices to adult family planning, and the genetic counselor's role throughout.
Rare disease
Exact Sciences
Madison, WI
Genetic testing laboratories
Genetic testing company, now part of Abbott, offering germline exome and panel testing through its PreventionGenetics lab plus a multi-cancer early detection blood test.
Booth
Exhibiting at Booth 1069
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Wed Nov 11
7:45–8:30am
Decoding Multi-Cancer Early Detection (MCED) Testing: The Science and Evidence Behind the Cancerguard® Test
Explains how Exact Sciences' Cancerguard multi-cancer early detection test combines DNA methylation and protein markers, and how to read its evidence.
Cancer
Genetic testing laboratories
Clinical genetic testing laboratory focused on exome and genome sequencing for rare disease diagnosis, drawing on a large rare disease dataset.
Booth
Exhibiting at Booth 969
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Wed Nov 11
12:15–1:30pm
CSI: Clinical Sequencing Investigation: Applying Genomic Evidence to Solve the Case
An escape-room-style case where attendees use phenotype clues, variant evidence and AI prioritization tools to reach a genomic diagnosis.
Rare disease
Labcorp
Burlington, NC
Genetic testing laboratories
National clinical laboratory company, now including Invitae's genetic testing, offering diagnostics alongside drug development services.
Booth
Exhibiting at Booth 1377
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Thu Nov 12
12:15–1:30pm
The Next Wave: Preparing for the Age of Population Genomics as a Genetic Counselor
Reviews the evidence for population genomic screening and how genetic counselors can support education, consent and follow-up as it grows.
Population genomics
Lilly
Indianapolis, IN
Pharma and biotech companies
Global pharmaceutical company whose genetic medicine work includes gene therapy for hereditary hearing loss; sponsors a session on hearing loss genetic testing.
Booth
Exhibiting at Booth 1363
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Fri Nov 13
7:45–8:30am
Partners in Diagnosis: Collaborative Models for Genetic Testing and Counseling in Hereditary Hearing Loss
Uses hereditary hearing loss to show how genetic counselors, audiologists and otolaryngologists can team up so genetic testing is routinely offered.
Rare disease
Myriad Genetics
Salt Lake City, UT
Genetic testing laboratories
Genetic testing laboratory offering hereditary cancer risk testing, prenatal and carrier screening, and pharmacogenomic tests.
Booth
Exhibiting at Booth 1061
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Thu Nov 12
12:15–1:30pm
Innovations at Myriad Genetics: Firstgene® Multiple Prenatal Screen and Myrisk® with Riskscore® Breast Cancer Risk Assessment
Introduces Myriad's FirstGene multiple prenatal screen and updates to its MyRisk breast cancer risk assessment with RiskScore.
Prenatal and reproductive · Cancer

Explore the full NSGC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Baltimore. Leave your work email and we’ll be in touch.

Privacy

Download the full NSGC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from companies at NSGC 2026

Tell us what you sell and we’ll find the people at these companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

When and where was NSGC 2026?

NSGC 45th Annual Conference ran November 10–14, 2026, at the Baltimore Convention Center in Baltimore, MD.

What is NSGC 2026?

The National Society of Genetic Counselors’ 45th Annual Conference, held November 10–14, 2026 at the Baltimore Convention Center, with a virtual day on November 10. About 2,500 genetic counselors and other genetic healthcare professionals attend, from clinics and hospitals, genetic testing laboratories, industry and research. The program runs plenaries, educational sessions, workshops, abstract presentations and poster viewing, sponsored breakfast and lunch symposia, and an exhibit hall.

What is in this guide?

Every organization in the NSGC 2026 exhibit hall — 86 exhibitors with their booth numbers and the hall’s opening hours — and the 18 sponsored breakfast and lunch symposia on the program, each on its sponsor’s row with its day, time and a link to the organizer’s page for it (17 sponsors; 86 organizations in all). The guide does not list the program’s speakers: NSGC’s speaker list gives no employer, which appears only inside each speaker’s biography, so their organizations cannot be placed without reading about each person.

Where does this list come from?

The meeting’s public site: the exhibitor list with the profile each exhibitor published (54 of the 86 exhibitors had written a company description there), and the program, where each sponsored symposium names its sponsor. Short descriptions are condensed from an exhibitor’s profile or its own website, or state what is well established about the organization. Nothing here requires a login.

How are organizations typed?

By what each organization is or offers a genetic counselor: genetic testing laboratories, drug developers (most of them in rare disease), software and digital health companies, other service providers, clinics and hospitals, research institutes and registries, and patient advocacy groups, foundations and professional societies. The topic tags — prenatal and reproductive, hereditary cancer, rare disease and so on — come from an organization’s own exhibitor profile and website, and from the symposium it sponsors, at most three each.

How current is it?

Pulled from the meeting’s public exhibitor list and program on November 12, 2026, during the meeting. Exhibit hall hours are from the program.

Why are there no names?

This guide is about which organizations are in the room, not which people. It never publishes a person’s name.

Browse NSGC 2026 by

Exhibit hall

Organizations with their own page

86 organizations — every exhibitor and every organization with 1 or more presentations.

Not affiliated with or endorsed by the National Society of Genetic Counselors (NSGC). Organization details are derived from NSGC’s published exhibitor list and program, and each organization’s own website. Submit a correction